Labcorp director granted 773 restricted stock units

Labcorp Holdings Inc. director John H. Sampson received an equity award of 773 restricted stock units on February 10, 2026.

Rhea-AI Filing Summary

Labcorp Holdings Inc. director John H. Sampson received an equity award of 773 restricted stock units on February 10, 2026. The Form 4 reports this as an acquisition of derivative securities at a price of $0 per unit, held as direct beneficial ownership.

Each restricted stock unit represents the contingent right to receive one share of Labcorp common stock. The 773 restricted stock units vest fully on February 10, 2027, and the filing shows 773 derivative securities beneficially owned following the reported transaction.

Insider Trade Summary

Grant/Award: 773 shares

Grant/Award 1 txn

Insider Sampson John H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	773	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 773 contracts (Direct)

Footnotes (2)

1. F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
2. F2. The Restricted Stock Units vest fully on February 10, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Labcorp (LH) director John H. Sampson report?

John H. Sampson reported receiving 773 restricted stock units from Labcorp as an equity award. The Form 4 classifies this as an acquisition of derivative securities at a price of $0 per unit, increasing his directly held derivative holdings to 773 units.

How many restricted stock units did John H. Sampson receive from Labcorp (LH)?

John H. Sampson received 773 restricted stock units from Labcorp. These units are reported as derivative securities, awarded on February 10, 2026, and bring his total beneficially owned derivative securities to 773 units according to the Form 4 filing.

When do John H. Sampson’s Labcorp (LH) restricted stock units vest?

The restricted stock units granted to John H. Sampson vest fully on February 10, 2027. Until vesting, they represent a contingent right to receive Labcorp common shares, as described in the Form 4 footnotes provided with the transaction details.

What does each restricted stock unit represent in the Labcorp (LH) Form 4 filing?

Each restricted stock unit represents the contingent right to receive one share of Labcorp Holdings Inc. common stock. This means the 773 units reported could convert into 773 common shares when they vest, assuming applicable vesting conditions are satisfied.

Is John H. Sampson’s ownership in Labcorp (LH) direct or indirect after this grant?

The Form 4 indicates John H. Sampson’s ownership of the 773 restricted stock units is direct. The ownership code is listed as “D” for direct, and no footnotes describe any trust, partnership, or other indirect holding structure for this particular equity award.

What transaction code is used for John H. Sampson’s Labcorp (LH) award?

The Form 4 uses transaction code “A” for John H. Sampson’s award, indicating a grant, award, or other acquisition. This code confirms the transaction is an acquisition of 773 restricted stock units rather than a sale or disposition of existing securities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/12/2026 - 11:09 AM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sampson John H

(Last) (First) (Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/10/2026		A		773		(2)	(2)	Common Stock	773	$0	773	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. The Restricted Stock Units vest fully on February 10, 2027.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for John H. Sampson	02/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.